DIFFERENCES IN NUTRITIONAL STATUS AND VASCULAR RISK FACTORS IN PATIENTS WITH PSORIATIC ARTHRITIS VS. ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Cazot, V. [1 ]
Corbacho, I. [1 ]
机构：
[1] Soc Uruguaya Reumatol, Montevideo, Uruguay
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
107
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [31] CURRENT NEEDS, IMPACT AND PERSPECTIVE OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS
    Plazuelo-Ramos, P.
    Loza, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 263 - 264
  • [32] Discontinuation of Methotrexate or TNF Inhibitors in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    George, Michael D.
    Baker, Joshua F.
    Ogdie, Alexis
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [33] Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
    Poddubnyy, Denis
    Rudwaleit, Martin
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (04) : 655 - 673
  • [34] Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
    Ogdie, Alexis
    de Vlam, Kurt
    McInnes, Iain B.
    Mease, Philip J.
    Baer, Philip
    Lukic, Tatjana
    Gruben, David
    Kwok, Kenneth
    Wang, Cunshan
    Hsu, Ming-Ann
    Maniccia, Anna
    RMD OPEN, 2020, 6 (01):
  • [35] The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
    Furst, Daniel E.
    Kay, Jonathan
    Wasko, Mary Chester
    Keystone, Edward
    Kavanaugh, Arthur
    Deodhar, Atul
    Murphy, Frederick T.
    Magnus, Jeanette H.
    Hsia, Elizabeth C.
    Hsu, Benjamin
    Xu, Stephen
    Rahman, Mahboob U.
    Doyle, Mittie K.
    RHEUMATOLOGY, 2013, 52 (10) : 1845 - 1855
  • [36] EFFECT OF TOFACITINIB ON REDUCING PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Ogdie, A.
    de Vlam, K.
    McInnes, I. B.
    Mease, P. J.
    Baer, P.
    Lukic, T.
    Kwok, K.
    Wang, C.
    Hsu, M. -A.
    Maniccia, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 971 - 972
  • [37] PATIENT CHARACTERISTICS AND GOLIMUMAB UTILIZATION IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
    Tandon, N.
    Haas, S.
    Bolge, S.
    Gunnarsson, C.
    VALUE IN HEALTH, 2012, 15 (04) : A48 - A48
  • [38] DURATION OF SYMPTOMS BEFORE DIAGNOSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Sorensen, J.
    Hetland, M. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 80 - 81
  • [39] A QUANTITATIVE ASSESSMENT OF ADHERENCE TO DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Raghunath, S.
    Dissanayake, K.
    Goldblatt, F.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 17 - 17
  • [40] Effect of Tofacitinib on Reducing Pain in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
    Ogdie, Alexis
    de Vlam, Kurt
    McInnes, Iain B.
    Mease, Philip J.
    Baer, Philip
    Lukic, Tatjana
    Kwok, Kenneth
    Wang, Cunshan
    Hsu, Ming-Ann
    Maniccia, Anna
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345